Over the past decades, the increase in premature babies has become a challenging issue across the globe. Unlike the healthy newborns, premature babies may have more health problems, which include brain, heart, eyes, and respiratory issues. Because of having premature lungs, most premature babies have breathing difficulties to survive.
Neonatal respiratory distress syndrome (RDS) affects approximately 40,000 infants each year in the United
States. Although the mortality rate has decreased dramatically over past decades, many
infants still perish or have chronic conditions that are associated with the treatment of the syndrome
(i.e., oxygen and positive pressure).
RDS is a disease of prematurity. The incidence increases with decreasing gestational age, occurring in
more than 80% in neonates less than 28
weeks. The major factors in the pathophysiology of RDS include surfactant deficiency,
underdeveloped alveolar units and capillaries and decreased alveolar surface area, reduced lung
compliance, poor gas exchange, and the presence of a ductus arteriosus.
Outlines the pathophysiologic events associated with RDS. A qualitative decrease in surfactant increases alveolar surface tension forces, which causes alveoli to become unstable and collapse and leads to atelectasis and increased work of breathing (WOB).
At the same time, the increased surface tension draws fluid. From the capillaries into the alveoli.
In combination, these factors impair oxygen (O2) exchange and cause severe hypoxemia. The severe hypoxemia and acidosis increase pulmonary vascular resistance (PVR).
As pulmonary arterial pressure increases, pulmonary right-to-left shunting increases, and hypoxemia worsens.
Hypoxemia and acidosis also impair further surfactant production.
The first signs of respiratory distress in infants with RDS normal appear soon after birth. Tachypnea usually occurs first. After tachypnea, worsening retractions, paradoxical breathing, and audible grunting are observed. Nasal flaring also may be seen. Chest auscultation often reveals fine inspiratory crackles. Cyanosis may or may not be present. If central cyanosis is observed, it is likely that the infant has severe hypoxemia. Certain other conditions, such as systemic hypotension, hypothermia, and poor perfusion, can mimic this aspect of RDS.
A definitive diagnosis of RDS usually is made with chest x-ray. Diffuse, hazy, ground-glass appearance or reticulogranular densities with the presence of air bronchograms with low lung volumes are typical of RDS. The reticulogranular pattern is caused by aeration of respiratory bronchioles and widespread alveolar collapse. Air bronchograms appear as aerated, dark, major bronchi surrounded by the collapsed or consolidated lung tissue.
Continuous positive airway pressure (CPAP), surfactant replacement therapy, and mechanical ventilation with conventional or high frequency ventilation (HFV), are common interventions used to manage RDS High-flow nasal cannula (HFNC), Nasal Intermittent Mandatory Ventilation (NIMV), and unless the infant’s condition is severe (high WOB, FiO₂ >0.4, and/or severe apnea), a trial of nasal CPAP is indicated (4 to 6 cm H₂O). Because of the hazards of endotracheal tubes (ETTs), nasal prongs or mask are preferred.
If the infant’s clinical condition deteriorates rapidly, a more aggressive approach is required.
intubation should be performed under controlled conditions as an elective procedure. Mechanical ventilation with positive end-expiratory pressure (PEEP) should be initiated if gas exchange does not improve with CPAP or if the patient’s frequent apnea does not respond to stimulation.
Underwater bubble CPAP (B-CPAP) and ventilator-derived CPAP (V-CPAP) are two of the most popular CPAP
modes, and they use different pressure sources. In V-CPAP, a variable resistance in a valve is adjusted
to provide resistance to the flow of air. In B-CPAP the positive pressure in the circuit is achieved by
simply immersing the distal expiratory tubing in a water column to a desired depth rather than using a
Based on results, B-CPAP is superior to V-CPAP in terms of treatment of
RDS in preterm infants due to fewer complications, shorter hospital stay, and lower cost. The simplicity
and low cost of B-CPAP compared with V-CPAP makes it an attractive option in resource-poor setups.
According to research Iran J Pediatr. 2011 Jun; 21(2): 151–158.